Prelude Capital Management’s Kyverna Therapeutics KYTX Stock Holding History

Prelude Capital Management’s Portfolio KYTX Stock Details KYTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$117K	Sell
2025 Q2	$111K	Sell
2025 Q1	$130K	Buy
2024 Q4	$164K	Buy
2024 Q3	$105K	Buy